GSK and Amgen join the TrumpRx platform, a White House-backed initiative aimed at lowering U.S. prescription drug prices and ...

A key FDA vaccine official is leaving the agency, raising questions about regulatory leadership, vaccine oversight, and the ...

Microsoft’s new healthcare AI chatbot could transform clinical decision support, helping doctors analyze medical data and streamline patient care.

China approves Pfizer’s GLP-1 weight-loss drug, expanding competition in the booming obesity treatment market and highlighting rising metabolic health concerns.

Proposed nuclear regulatory changes could reshape America’s energy future, sparking debate over safety, innovation, and the role of nuclear power.

Healthcare spending in the United States continues to place an increasing burden on households, as insurance premiums, prescription drug prices, and out-of-pocket expenses climb faster than wages in ...

Balcony solar systems are quietly transforming clean energy access. Discover how plug-in solar works, its legal challenges, ...

A new U.S. autism research panel is examining potential causes of autism, sparking debate over science, policy, and the ...

The FDA’s dispute with biotech firm uniQure over Huntington’s gene therapy highlights growing tensions between innovation, ...

Bayer’s $7.25B Roundup settlement gains initial approval in Missouri, potentially resolving thousands of cancer lawsuits tied to glyphosate exposure.

CDC faces leadership exodus amid policy disputes, raising concerns over scientific independence and outbreak readiness.

Four earthquakes up to magnitude 4.0 shook Louisiana, raising questions about hidden faults, seismic risks, and the region’s rarely studied geology.